<DOC>
	<DOCNO>NCT00004994</DOCNO>
	<brief_summary>This study examine quality life patient undergo bone marrow transplantation treat blood disease . It look therapy affect many area life , include example , personal relationship , work , general emotional state . The information gain may lead improved way deal problem may arise treatment . Patients receive bone marrow stem cell donate family member may participate study . They interview treatment begin complete questionnaire follow interval : 1. day admission hospital 2. day transplant 3 . 30 day transplant 4 . 100 day transplant 5 . 1 year therapy 6 . 2 year therapy All questionnaire complete discharge hospital schedule regular follow-up visit . Each questionnaire take 15 20 minute complete . The information provide confidential share .</brief_summary>
	<brief_title>Comparison Quality Life Patients Undergoing More Intensive Versus Less Intensive Chemotherapy Radiation Preceding Bone Marrow Transplant</brief_title>
	<detailed_description>Clinical research blood stem cell bone marrow transplantation document improvement disease free interval , disease free survival , severity treatment related toxicity . However , important patient family know quality life ( QOL ) expect follow allogeneic transplant . In longitudinal study compare QOL patient undergo non-myeloablative allogeneic peripheral blood stem cell transplant ( A-PBSCT ) prospectively myeloablative A-PBSCT . Subjects ( n=106 ) age 18 enrol . Measures quality life ( Medical Outcomes Study Short Form-MOS SF-36 Functional Assessment Cancer Therapy-General Bone Marrow Transplant - FACT-G FACT-G/BMT ) symptom distress ( Symptom Distress Scale - SDS ) administer prior transplant ( baseline ) set interval post transplant . Data analyze use repeat measure analysis variance regression analysis .</detailed_description>
	<criteria>INCLUSION CRITERIA : Male female subject 18 year age old . Able read English Spanish . Hematological disease require APBSCT . Signed informed consent QOL study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Allogeneic Transplant</keyword>
	<keyword>Function</keyword>
	<keyword>Mini-Transplant</keyword>
	<keyword>Physical Symptoms</keyword>
	<keyword>Symptom Distress</keyword>
</DOC>